AN

Welcome to the Brand page for “AN”, which is offered here for Education services, providing classes, seminars, and workshops in the field alpha-1 antitrypsin deficiency; providing on-line publications in the nature of guides and newsletters in the field of alpha-1 antitrypsin deficiency; training of study staff in the field of alpha-1 antitrypsin deficiency and clinical trials;the mark consists of the letters an in a stylized format.;downloadable electronic publications in the nature of informational and educational materials, booklets, in the field of alpha-1 antitrypsin deficiency; downloadable multimedia files containing artwork, text, audio and video relating to alpha-1 antitrypsin deficiency; pre-recorded electronic media in the field of alpha-1 antitrypsin deficiency;in the statement, page 2, column 2, lines 4-6, should be deleted, and providing support and assistance in the nature of counseling to individuals affected by alpha-1 antitrypsin deficiency; identifying qualified study sites, inspection of laboratory research facilities for safety purposes should be inserted.;printed informational and educational materials, booklets and reference guides, in the field of alpha-1 antitrypsin deficiency;alpha net;charitable services, providing financial support for clinical research to improve the lives of individuals affected by alpha-1 antitrypsin deficiency;color is not claimed as a feature of the mark.;*providing support and assistance in the nature of counseling to individuals affected by alpha-1 antitrypsin deficiency;* identifying qualified study sites, inspection of laboratory research facilities for safety purposes;health care services, disease management for individuals affected by alpha-1 antitrypsin deficiency; providing support and assistance services to inform individuals affected by alpha-1 antitrypsin deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing links to the web sites of others featuring information about the diagnosis, management and treatment of alpha-1 antitrypsin deficiency; providing health and medical care information to individuals affected by alpha-1 antitrypsin deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing support and assistance in the nature of health and wellness counseling to individuals affected by alpha-1 antitrypsin deficiency;providing medical and scientific research information in the field of alpha-1 antitrypsin deficiency; consultation services in the field of facilitating and conducting clinical trials involving human subjects of new treatment options for individuals affected by alpha-1 antitrypsin deficiency in the nature of identifying qualified study sites and researchers and encouraging study enrollment; providing quality assurance services in the field of clinical trials by generating and monitoring study data and documentation thereof for quality assurance purposes;.

Its status is currently believed to be active. Its class is unavailable. “AN” is believed to be currently owned by “AlphaNet, Inc.”